Predictive Value of PS Application in Premature Infants With RDS

NCT ID: NCT05772247

Last Updated: 2023-03-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

1392 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-04-01

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A multicenter prospective study was conducted to compare the predictive value of 6-zone, 10-zone, and 12-zone LUS scores for PS application in early and late preterm infants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Respiratory Distress Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

PS application

Lung ultrasound

Intervention Type DIAGNOSTIC_TEST

Lung ultrasound score was calculated by the results of lung ultrasound examination

non-PS application

Lung ultrasound

Intervention Type DIAGNOSTIC_TEST

Lung ultrasound score was calculated by the results of lung ultrasound examination

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lung ultrasound

Lung ultrasound score was calculated by the results of lung ultrasound examination

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Hospital admission within 2 hours after birth;
2. The diagnosis was RDS;
3. Parents agree to attend

Exclusion Criteria

1. chromosomal abnormalities or complex congenital malformations;
2. congenital pulmonary disease;
3. severe sepsis, disseminated intravascular coagulation, septic shock and other critical conditions;
4. LUS and blood gas analysis have been examined before the application of alveolar surfactant.
Minimum Eligible Age

1 Day

Maximum Eligible Age

1 Month

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The First Hospital of Jilin University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FirstJilinU2

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lung Ultrasound - Prospective Study
NCT06140615 ACTIVE_NOT_RECRUITING NA
LUS AT BIRTH IN INFANTS BORN BEFORE 26 WEEKS
NCT06394583 NOT_YET_RECRUITING